date:May 09, 2013
disclose any of eight identified allergens in the labeling and marketing of products.
In addition to discontinuing the sale of artriphen, XYMOGEN is phasing out two other products, coolsens and dolorox, provided by the same company, neither of which has any known safety concerns.
artriphen was available in quantities of either 90 or 180 capsules.